← Insider buys
RNA

Atrium Therapeutics, Inc. · Healthcare

CFO Michael F Maclean sold $2.1M of Atrium Therapeutics, Inc.

Sold$2,121,045
$28.28Price
75,000Shares
−63%Stake

What RNA did after the filing

Prices for RNA after this filing aren't in yet.

Traded Tue, May 14. Filed Thu, May 16, 6:25 PM ET, after the close. Not investment advice.